Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Prevnar Supply “Bottleneck” Will Let Up In Mid-2002, Firm Says

Executive Summary

Wyeth-Ayerst hopes to wrap-up discussions with FDA over the product release process for Prevnar to alleviate a supply "bottleneck" by mid-2002

You may also be interested in...



Wyeth Prevnar Allocation Plan Extended To July; Four-Dose Schedule On Hold

Wyeth's Prevnar allocation program will run until at least mid-July, with shipments to providers cut by 20%

Wyeth Prevnar Allocation Plan Extended To July; Four-Dose Schedule On Hold

Wyeth's Prevnar allocation program will run until at least mid-July, with shipments to providers cut by 20%

Wyeth Prevnar Allocation Plan Could Run Through March

Wyeth expects an allocation program for Prevnar could be in place through March

Related Content

UsernamePublicRestriction

Register

PS038803

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel